ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

High levels of Tim-3+Foxp3+Treg cells in the tumor microenvironment is a prognostic indicator of poor survival of diffuse large B cell lymphoma patients

Zhong, Weijie; Liu, Xiudan; Zhu, Zhigang; Li, Qingshan*; Li, Kangbao*1
International Immunopharmacology2021-7DOI: 10.1016/j.intimp.2021.107662
10被引9阅读
引用收藏
分享

摘要

Foxp3(+)Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvimnment (TME) of colorectal and lung cancer. High abundance of Tim-3(+)Foxp3(+)Treg (TFT) cells are associated with poor prognosis in these patients. However, the expression patterns and roles of TFT cells in TME of diffuse large B cell lymphoma (DLBCL) remain to be established. Double immunofluorescence and flow cytometry analyses were employed to investigate TFT cell enrichment in paraffin-embedded fresh tumor tissues from patients with DLBCL. Spearman's or Pearson's correlation and Kaplan-Meier survival analyses were further applied to decide the prognostic value of TFT cell levels in DLBCL. The IL-10-secreting function of TFT cells in vitro was examined via flow cytometry and ELISA. Our results showed for the first time that TFT cells are highly enriched in TME of DLBCL patients and associated with predictions of poor prognoses. TFT cell-induced secretion of IL-10 in the TME was suppressed by an anti-Tim-3 antibody in vitro. In conclusion, high abundance of TFT cells in the TME is predictive of poor outcomes of DLBCL. TFT cells promote DLBCL development partly by secreting IL-10 in the TME. Anti-Tim-3 antibodies (that block IL-10 secretion) may present an effective therapeutic agent for DLBCL.

学科与关键词

关键词
Tim-3(+)Foxp3(+)Treg cellsTim-3Tumor microenvironmentPrognostic factorsDiffuse large B cell lymphoma
相关
加载中…
  • Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
    Xu, Yongpeng; Zhou, Xinglu; Zhang, Shuai; Nanding, Abiyasi; Xuan, Qijia*OncoTargets and Therapy, 2022, 15: 181-191.被引 2
  • Human FOXP3 and tumour microenvironment
    Wang, Jia; Gong, Ruining; Zhao, Chenyang; Lei, Ke; Sun, Xiaoyuan; Ren, He*Immunology, 2023, 168(2): 248-255.被引 28
  • An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
    Liang, Xiao-Jie; Fu, Rui-ying; Wang, He-nan; Yang, Jing; Yao, Na; Liu, Xin-di; Wang, Liang*Journal of Immunology Research, 2021, 2021: 5564568.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2021-07
卷期
第 96 卷
页码
107662
DOI
10.1016/j.intimp.2021.107662
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Guangzhou Planned Project of Science and Technology, China [202002030175]; Guangdong Medical Science and Research Foundation, China [A2020188]; Guangdong Science and Research Project of Traditional Chinese Medicine Bureau, China [20201252]; Fundamental Research Funds for the Central Universities, SCUT, China [D2200420]

作者

  • Z

    Zhong, Weijie (第一作者)

    1

  • L

    Liu, Xiudan

    1

查看全部 5 位作者收起作者
  • Z

    Zhu, Zhigang

    1

  • L

    Li, Qingshan (通讯)

  • L

    Li, Kangbao (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417